We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.52B
AUM Growth
+$912M
Cap. Flow
+$556M
Cap. Flow %
10.07%
Top 10 Hldgs %
28.84%
Holding
130
New
8
Increased
98
Reduced
11
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Industrials 19.35%
3 Healthcare 14.93%
4 Consumer Discretionary 10.52%
5 Consumer Staples 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHD
1
DELISTED
Cepheid Inc
CPHD
$224M 4.06%
4,791,847
+1,341,677
+39% +$56.9M
ULTI
2
DELISTED
Ultimate Software Group Inc
ULTI
$189M 3.43%
1,232,846
+83,915
+7% +$12.7M
NATI
3
DELISTED
National Instruments Corp
NATI
$159M 2.88%
4,966,070
+541,849
+12% +$16.7M
CSGP icon
4
CoStar Group
CSGP
$12.1B
$154M 2.79%
8,333,400
+293,930
+4% +$5.2M
ATHN
5
DELISTED
Athenahealth, Inc.
ATHN
$151M 2.73%
1,121,012
+125,950
+13% +$16.2M
PRAA icon
6
PRA Group
PRAA
$685M
$147M 2.66%
2,779,576
+310,155
+13% +$17.6M
UNFI icon
7
United Natural Foods
UNFI
$3.07B
$146M 2.65%
1,937,037
+214,074
+12% +$15.1M
GNTX icon
8
Gentex
GNTX
$5.15B
$142M 2.58%
8,619,848
+725,062
+9% +$10.6M
RBA icon
9
RB Global
RBA
$21.4B
$141M 2.57%
6,170,658
+2,139,869
+53% +$43.8M
MMS icon
10
Maximus
MMS
$3.33B
$138M 2.5%
3,130,342
+359,154
+13% +$16.5M
LOPE icon
11
Grand Canyon Education
LOPE
$4.16B
$131M 2.38%
3,005,485
+391,874
+15% +$17.2M
MD icon
12
Pediatrix Medical
MD
$2.17B
$130M 2.36%
2,438,379
+255,189
+12% +$13.7M
BECN
13
DELISTED
Beacon Roofing Supply, Inc.
BECN
$126M 2.29%
3,137,012
+340,153
+12% +$12.3M
ROL icon
14
Rollins
ROL
$18.9B
$124M 2.24%
13,791,317
+1,595,410
+13% +$13.3M
TRAK
15
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$123M 2.23%
2,556,328
+296,315
+13% +$12.3M
CHE icon
16
Chemed
CHE
$7.13B
$117M 2.12%
1,529,459
+159,256
+12% +$11.7M
NEOG icon
17
Neogen
NEOG
$2B
$113M 2.06%
6,615,539
+782,095
+13% +$13.6M
IPCM
18
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$112M 2.03%
1,884,099
+193,425
+11% +$11M
TECH icon
19
Bio-Techne
TECH
$11.2B
$107M 1.94%
4,509,996
+177,252
+4% +$3.84M
LKQ icon
20
LKQ Corp
LKQ
$6.78B
$103M 1.87%
3,131,038
-1,221,746
-28% -$39.9M
MINI
21
DELISTED
Mobile Mini Inc
MINI
$99.1M 1.8%
2,407,348
-1,567
-0.1% -$58.3K
PRLB icon
22
Protolabs
PRLB
$1.7B
$96.5M 1.75%
1,355,185
+155,157
+13% +$12M
ABCO
23
DELISTED
Advisory Board Co
ABCO
$88M 1.6%
1,381,680
+329,531
+31% +$21M
CCMP
24
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$87.1M 1.58%
1,906,966
+185,930
+11% +$7.86M
SRCL
25
DELISTED
Stericycle Inc
SRCL
$81.6M 1.48%
702,407
+55,671
+9% +$6.49M

Similar funds

Riverbridge Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Riverbridge Partners held 130 positions worth $5.52B, up 20% from $4.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Riverbridge Partners deployed $556M of net new capital in Q4 2013, opening 8 new positions and adding to 98 existing holdings. Its largest new stake was CHANNELADVISOR CORPORATION: 1,109,610 shares worth $46.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Hormel Foods, an estimated $56M trimmed.

  • Riverbridge Partners's largest Q4 2013 buy was CHANNELADVISOR CORPORATION: 1,109,610 shares worth $46.3M.
  • Riverbridge Partners added most to Cepheid Inc in Q4 2013, an estimated $56.9M increase.
  • Riverbridge Partners's biggest Q4 2013 reduction was Hormel Foods, cutting an estimated $56M.
  • Riverbridge Partners fully exited GREENWAY MED TECHNOLOGIES INC CPM STK (DE) in Q4 2013, selling an estimated $43.6M.
  • Riverbridge Partners's ten largest holdings make up 29% of its $5.52B portfolio in Q4 2013.
  • Riverbridge Partners opened 8 new positions and closed 4 in Q4 2013.
  • Riverbridge Partners's portfolio value rose 20% quarter-over-quarter to $5.52B.

Based on Riverbridge Partners's 13F filing for Q4 2013, filed 10 Feb 2014.